Form 4: Cardio Diagnostics Holdings Director Acquires Stock Options
SEC Form 4 Filing
Director James Intrater acquired 7,575 stock options in Cardio Diagnostics Holdings, Inc. on June 30, 2024.
Summary
- On June 30, 2024, James Intrater, a director of Cardio Diagnostics Holdings, Inc., acquired 7,575 stock options.
- The exercise price of these options is $0.55.
- The options are exercisable immediately and expire on June 30, 2034.
- Following the transaction, Intrater directly owns 7,575 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to insider transactions, and does not inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction could be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of earliest transaction: Acquisition of stock options. |
| 06/30/2024 | Date the stock options were acquired and exercisable. |
| 06/30/2034 | Expiration date of the stock options. |
| 07/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.